title: Effects of antihypertensive medications on vitality and well-being.
abstract: The effects of captopril, methyldopa, and propranolol were assessed for sense of well-being and vitality among 626 men with mild to moderate hypertension in a multicenter, randomized, double-blind clinical trial. After a 24-week treatment period, patients taking captopril, compared with patients taking methyldopa and propranolol, scored significantly higher on measures of well-being and vitality. In addition, patients on captopril had more favorable results in being able to keep up with their work and in not feeling tired or sleepy at work. The effects of each of the drugs manifested themselves at different periods. For example, the negative effects of methyldopa on vitality were evident by week 8, whereas the negative effects did not become manifest for propranolol until week 24. On the other hand, a steady progressive improvement in vitality scores was evident at week 8 and at week 24 for patients on captopril. The findings of the study also suggest that the effects of the treatment drugs were most marked in patients who had had previous antihypertensive medications and who were on single-drug therapy during the course of the clinical trial. Further, the differences between patients taking captopril and those on methyldopa and propranolol appear to be obscured by the addition of a diuretic. The findings of the study may guide the physician in orienting his or her patient and in planning and implementing a therapeutic regimen.
authors.affiliation: University Professors Program, Boston University, MA 02115.
authors.forename: S
authors.initials: S
authors.lastname: Levine
authors.forename: S H
authors.initials: SH
authors.lastname: Croog
authors.forename: A
authors.initials: A
authors.lastname: Sudilovsky
authors.forename: M A
authors.initials: MA
authors.lastname: Testa
mesh_terms: D000223:Adaptation, Psychological / Q000187:drug effects*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001294:Attitude to Health; D002216:Captopril / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000627:therapeutic use; D004311:Double-Blind Method; D005221:Fatigue / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000523:psychology; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011788:Quality of Life; D011897:Random Allocation; D013997:Time Factors; D014940:Work Schedule Tolerance
chemical_list: D000959:Antihypertensive Agents; D004232:Diuretics; D008750:Methyldopa; D002216:Captopril; D011433:Propranolol